NCT01636726View on ClinicalTrials.gov

WEUKBRE5554: IMI PROTECT(Work Package 2): Beta2 Agonists and Acute Myocardial Infarction

CompletedOBSERVATIONAL

Enrollment

1

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions

Asthma

Interventions

DRUG

Inhaled LABA use

LABA prescription during the study period between Jan 1, 2002 and Dec 31, 2009

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY